Literature DB >> 25190922

A novel method for blood volume estimation using trivalent chromium in rabbit models.

Prathap Moothamadathil Baby1, Pramod Kumar2, Rajesh Kumar3, Sanu S Jacob4, Dinesh Rawat5, V S Binu6, Kalesh M Karun6.   

Abstract

BACKGROUND: Blood volume measurement though important in management of critically ill-patients is not routinely estimated in clinical practice owing to labour intensive, intricate and time consuming nature of existing methods. AIMS: The aim was to compare blood volume estimations using trivalent chromium [(51)Cr(III)] and standard Evans blue dye (EBD) method in New Zealand white rabbit models and establish correction-factor (CF).
MATERIALS AND METHODS: Blood volume estimation in 33 rabbits was carried out using EBD method and concentration determined using spectrophotometric assay followed by blood volume estimation using direct injection of (51)Cr(III). Twenty out of 33 rabbits were used to find CF by dividing blood volume estimation using EBD with blood volume estimation using (51)Cr(III). CF is validated in 13 rabbits by multiplying it with blood volume estimation values obtained using (51)Cr(III).
RESULTS: The mean circulating blood volume of 33 rabbits using EBD was 142.02 ± 22.77 ml or 65.76 ± 9.31 ml/kg and using (51)Cr(III) was estimated to be 195.66 ± 47.30 ml or 89.81 ± 17.88 ml/kg. The CF was found to be 0.77. The mean blood volume of 13 rabbits measured using EBD was 139.54 ± 27.19 ml or 66.33 ± 8.26 ml/kg and using (51)Cr(III) with CF was 152.73 ± 46.25 ml or 71.87 ± 13.81 ml/kg (P = 0.11).
CONCLUSIONS: The estimation of blood volume using (51)Cr(III) was comparable to standard EBD method using CF. With further research in this direction, we envisage human blood volume estimation using (51)Cr(III) to find its application in acute clinical settings.

Entities:  

Keywords:  Blood volume; Evans blue dye; measurement; trivalent chromium

Year:  2014        PMID: 25190922      PMCID: PMC4147461          DOI: 10.4103/0970-0358.138961

Source DB:  PubMed          Journal:  Indian J Plast Surg        ISSN: 0970-0358


INTRODUCTION

Blood volume estimation is one of the cardinal parameter necessary in cases of burns, sepsis, management of critically ill-patients undergoing major surgeries and in intensive care settings.[12] Considerable blood volume depletion or hypovolemia leads to clinically identifiable “shock,” which requires emergency intervention. Smaller blood volume depletion leads to normotensive compensated shock associated with vasoconstriction of visceral organs such as gastrointestinal tract, skin, and kidneys. This diminished perfusion to the splanchnic organs results in inadequate oxygenation to the gut mucosa precipitating to a cascade of pathophysiological events proceeding to development of sepsis.[3] The existing approaches for blood volume estimations are labour intensive, intricate and time consuming. In the last many years, research has brought various methods for blood volume estimation. The widely used methods employ dye dilution and radioisotope techniques. The dye dilution technique using Evans blue dye (EBD) method has limitations due to hypersensitivity reactions in patient and tissue discoloration. The radioisotope labelling methods involving either albumin or red blood cells (RBCs) is time consuming, cumbersome and cannot be repeated on the same patient due to the prolonged stay of radioactive material in the body in the labelled form.[4] The gold standard method of blood volume estimation using radioisotopes, though accurate has complex procedures, forcing the clinicians to opt and practice on easier and less accurate methods such as history, physical examination, systemic blood pressure, central venous pressure and urine volume.[567] It is important to note these methods do not allow for calculation of absolute blood volume. Available reports indicate inaccurate volume assessment holds many risk factors, often leading to inappropriate, unnecessary therapeutic intervention and mortal outcomes.[8] The aim of this experimental study using New Zealand white rabbit model was to compare blood volume estimation using [51Cr(III)] with that of EBD method and to establish a correction-factor (CF), which can be further related for human application.

MATERIALS AND METHODS

The study was approved by the institutional animal ethics committee. A total of 33 New Zealand white rabbits (Oryctolagus cuniculus), which includes 11 males and 22 females weighing approximately 1.5-3.1 kg were used in this experiment. All animals were kept on dietary restriction to stabilise fluctuations in blood volume during the experimental period. Ten minutes before the experiment, rabbits were placed in restrainer and anaesthetised with ketamine hydrochloride (25 mg/kg body weight) injection through the marginal ear vein. The site of injection and blood sample collection was prepared by shaving the area on both ear and gently wiping with 70% alcohol swab. An intravenous (IV) cannula of 26 GA (BD Neoflon™ Singapore) was inserted to the marginal vein of one of the ear and secured it with an adhesive plaster. This was used for injection of drug or dye in to the vascular system. In to the other ear to withdraw blood a 24 GA (BD Neoflon™ Singapore) IV cannula was placed in the central auricular artery and secured with an adhesive plaster. All animals were assigned to go through blood volume measurement using EBD method described by Armin et al. followed by 51Cr(III).[49] An initial (blank) blood sample of 3.2 ml was withdrawn from the auricular artery followed by injection of 1 ml of 0.2% EBD (Himedia Lab. Pvt. Ltd, Mumbai) solution in normal saline through the marginal vein. Subsequently, 0.5 ml saline was used to wash the injected dye. After 8 min, another 2.2 ml blood sample was withdrawn and after this at every 8 min interval three 2.2 ml blood samples were withdrawn. All samples were collected in heparinised vacutainer and plasma separated from whole blood samples. EBD content was determined by means of a spectrophotometric assay (Thermo scientific GENESYS 10UV, USA). A volume of 1 ml plasma of each blood sample was placed in a 1 ml spectrometer cuvette and the absorbance read at 650 nm. The concentration of dye was calculated from the standard curve of EBD solution in pooled plasma of rabbits.[10] Plasma volume V, was obtained from Where; Cst = Dye concentration of standard (2000 μg/ml) V = Volume of injected EBD Csa = Dye concentration of samples corrected for dye loss and for spontaneous dilution.

Correction for spontaneous dilution of the blood

Intermittent blood withdrawal from rabbit in a brief time period often leads to slight decrease in levels of plasma proteins, which leads to alteration of plasma EBD concentration during measurements. Noble et al. suggested a formula for correction of fluid shift assuming that the proportion of T-1824 labelled protein to total protein remains constant during the experiment.[1112] Where; C = Corrected concentration of the nth sample of plasma with dye Cn = The observed concentration of dye in the nth sample A1 = The total protein concentration of the 1st plasma sample with dye An = The total protein concentration of the nth dyed sample.

Determination of Csa

Csa is the concentration of dye that would be found if the T-1824 were distributed without loss through circulating plasma. This concentration is required in calculating the plasma volume. Estimation of Csa was done by extrapolation back to zero time.[9]

Determination of haematocrit

Haematocrit was measured by centrifuging 100 mm columns of blood in 3 mm bore Wintrobe tube at 3000 rpm for 30 min in a centrifuge head of 15 cm radius.[13] All packed cell volume measurements were multiplied by 0.95, since 5% of the packed cell volume consists of plasma.

Calculation of blood volume

Estimation of blood volume was calculated from measured plasma volume and haematocrit,[14]

Blood volume estimation using 51Cr(III)

2 mCi of 51Cr in aqueous solution was obtained from Board of Radiation and Isotope Technology, DAE, GOI. Two hours prior to the estimation of blood volume using 51Cr(III), a syringe was loaded with 51Cr(III) by reducing 51Cr in aqueous solution with freshly prepared ascorbic acid (Sisco Research Laboratories Pvt. Ltd, Mumbai.) solution (0.2 mg/ml), which is sufficient to transform entire 51Cr in aqueous solution to 51Cr(III).[15] Activity of the loaded syringe was determined in a calibrated Nucleonix Gamma Ray Spectrometer having NaI (Tl) based well type scintillation detector coupled to single channel analyser. Approximately, 3000 counts per second (cps) of 51Cr(III) in 1 ml were injected initially to the animal through the IV cannula inserted to the marginal vein followed by 0.5 ml saline to wash the injected 51Cr(III) solution. The syringe used for injection of the dose then collected and measured for the remaining activity. The dose mentioned above is the actual dose that has gone in to the animal by subtracting the left over activity in the syringe. An electronic timer was preset for a minute before the experiment and switched on immediately following injection. After a minute, 1 ml blood sample were obtained after dilution from the central artery and its activity determined in a well type scintillation counter for 360 s. Blood volume was obtained from the equation, Where; C1 = Concentration of tracer injected C2 = Concentration of the tracer in the unknown volume V1 = Volume of tracer injected V2 = Unknown volume to be measured

Development of correction-factor

Entire sample size (n = 33) were randomly divided using statistical package for social sciences (SPSS 15.0, IBM Corporation) in to two groups. The CF was calculated by dividing the estimated blood volume using EBD with blood volume estimated using radioactive 51Cr(III) as discussed by Modi et al.[16] Group I, with 60% of the total sample size (n = 20) were used to develop CF and the mean CF obtained. Group II, with 40% of the total sample size (n = 13) were used for validation of CF.

Validation of the correction-factor

The CF obtained from Group I was then applied to Group II by multiplying the CF to each value obtained in Group II. After applying CF, the data were analysed for any significant difference between Group II and blood volume estimation using Evans blue method.

Statistical analysis

Blood volume measurement using EBD and direct injection of 51Cr(III) were analysed using paired t-test and by the method of Bland and Altman plot for assessing the agreement between two methods of clinical measurement.[17] All results were expressed in mean ± standard deviation (SD) and P < 0.05 was considered to be statistically significant. SPSS 15.0 was used for the analysis.

RESULTS

The data of 33 rabbits shows a mean body weight of 2.18 ± 0.35 kg, mean arterial packed cell volume of 35.11 ± 3.85%. The mean circulating blood volume (CVB) using EBD was 142.02 ± 22.77 ml or 65.76 ± 9.31 ml/kg. In this group, subsequent determination of the mean CVB by injection of 51Cr(III) was estimated to be 195.66 ± 47.30 ml with the mean CVB being 89.81 ± 17.88 ml. On an average, 53.64 ml (95% confidence interval (CI) - 39.57, 66.86 ml) is the difference in blood volume between the two methods (P < 0.001). A Bland Altman plot of blood volume obtained using EBD and direct injection of 51Cr(III) is shown in Figure 1. The red line indicates the limits of agreement and green line indicates the mean of the two measurements. The limits of agreement were from −23.6 to 130.2 ml.
Figure 1

Blood volume obtained using Evans blue dye and direct injection of 51Cr(III) without applying correction-factor (n = 33)

Blood volume obtained using Evans blue dye and direct injection of 51Cr(III) without applying correction-factor (n = 33) Owing to the difference in the blood volume values in the two methods of blood volume estimation and a statistically significant difference therein, CF was developed. Among the 33 rabbits, 20 randomly selected rabbits (60% of total number) were used for the development of CF and the remaining 13 rabbits were used for validating the CF. The fourth column in Table 1 gives the ratio of the both methods. The mean and SD of the ratio is 0.77 ± 0.14, which was used as the CF. The values of 20 rabbits selected for CF development is given below in Table 1.
Table 1

Development of CF

Development of CF

Validation of correction-factor

In the validation group, mean blood volume of 13 rabbits measured using EBD was 139.54 ± 27.19 ml or 66.33 ± 8.26 ml/kg body weight. In the same group, blood volume measurement using 51Cr(III) without applying CF showed a mean blood volume of 199.21 ± 60.33 ml or 93.73 ± 18.01 ml/kg body weight. On an average, 59.67 ml (95% CI - 35.41, 83.94) is the difference between the two methods (P < 0.001). In the same group, the mean blood volume measurement by 51Cr(III) with CF was 152.73 ± 46.25 ml or 71.87 ± 13.81 ml/kg body weight. The average difference is 13.19 ml (95% CI - 3.44, 29.83) between the two methods (P = 0.110) [Table 2].
Table 2

Comparison of blood volume obtained by EBD, 51Cr(III) without applying CF and 51Cr(III) with CF

Comparison of blood volume obtained by EBD, 51Cr(III) without applying CF and 51Cr(III) with CF A Bland Altman plot for blood volume obtained using EBD and direct injection of 51Cr(III) with CF in the validation group is shown in Figure 2. The plot showed that the limits of agreement were from 68.26 to −41.86. The 95% CI for the lower limits of agreement is −70.68 to −13.04 ml and for the upper limit is 39.44-97.07 ml.
Figure 2

Blood volume obtained using Evans blue dye and direct injection of 51Cr(III) with correction-factor (n = 13)

Blood volume obtained using Evans blue dye and direct injection of 51Cr(III) with correction-factor (n = 13)

DISCUSSION

Accurate and rapid measurement of blood volume in critical care situations is a challenge for the clinicians in intensive care units. Inability to fix the volume status in hypovolemic situations increases morbidity and mortality in critically ill-patients. Although there are many techniques existing for measurement of CVB, there is dearth for a method, which is easy, reliable and repeatable in nature for use in routine clinical settings. The available methods are inherently complex and time consuming and most dye methods results in unacceptable levels of tissue discoloration and associated hypersensitivity reactions. Moreover, inaccuracies associated with radioactive labelled RBCs or albumin limits their use in blood volume measurement.[18] This study explores the possibility of using 51Cr(III) to overcome the shortcomings mentioned above. We compared the measurements obtained by trivalent chromium with that of EBD dilution technique. The blood volume values obtained by EBD method were comparable with the existing normal values available for New Zealand white rabbits.[1920] Initial experiments in rabbits using hexavalent chromium we observed higher blood volume values owing to the fact that during mixing it is permeable through the cell membranes and uptake by various tissues is comparatively higher leading to overestimation of blood volume. Subsequently, we used 51Cr(III), which is not permeable through cell membranes and relatively less up taken by various tissues as established by Gray and Sterling.[21] The blood volume values obtained with 51Cr(III) also showed significant difference with that of EBD method. This difference is attributed to the loss of 51Cr(III) in to the interstitial space, third space loss, excreted in urine and other body secretions. This loss of 51Cr(III) necessitates the development of CF. After applying CF to blood volume value obtained by 51Cr (III) in the validation group, the two methods were comparable and the mean difference between the two groups was 13.19 ml. Among the measured blood volume values of the 13 rabbits in the validation group, value of one of the rabbits was above two SD and this may be due to an experimental error. After eliminating this value, which was above two SD, the mean difference was found to be only 6.67 ml. In 2007, in a pilot study, we used hexavalent chromium to find a simple, quick and method, which can be used in clinical settings.[4] In this study with better understanding about loss of hexavalent chromium due to its ability to cross cell membranes, we selected trivalent chromium.[21] Time taken for blood volume estimation by EBD method in this study was approximately 1.7 h (average). This method is not used in human studies because of reports of tissue discoloration and suspicion of carcinogenicity.[3] The present experimental study was conducted in New Zealand white rabbits. Hence, it is not possible to compare cost with other available human studies without any extrapolation. On extrapolation of our experiment to human experiment for cost analysis, we found that total cost for one reference Indian adult will be approximately INR 1000. The time required for estimation was found to be 0.15 h, which is much less, compared to various methods quoted in the literature [Table 3].[22]
Table 3

Cost and time comparison with other human study

Cost and time comparison with other human study

CONCLUSION

The method offers an alternative for existing blood volume estimation methods which is easy, quick, can be done in clinical settings and repeatable as 51Cr(III) is not bound to albumin or RBCs. The values obtained are comparable with the standard Evans blue method with the CF. The validity of this technique in situations where cardiac output is very low is uncertain. We need to look at the applicability of this method in acute clinical settings and there is a need to develop CF for it. To conclude estimation of blood volume using 51Cr(III) was comparable to standard EBD method using CF. With further research in this direction we foresee human blood volume estimation using 51Cr(III) to find its application in acute clinical settings.
  22 in total

1.  A good practice guide to the administration of substances and removal of blood, including routes and volumes.

Authors:  K H Diehl; R Hull; D Morton; R Pfister; Y Rabemampianina; D Smith; J M Vidal; C van de Vorstenbosch
Journal:  J Appl Toxicol       Date:  2001 Jan-Feb       Impact factor: 3.446

2.  The plasma in the packed cell column of the haematocrit.

Authors:  D LEESON; E B REEVE
Journal:  J Physiol       Date:  1951-10-29       Impact factor: 5.182

3.  Clinical assessment of central venous pressure in the critically ill.

Authors:  D J Cook
Journal:  Am J Med Sci       Date:  1990-03       Impact factor: 2.378

Review 4.  Measurement of blood volume in surgical and intensive care practice.

Authors:  J G Jones; C A Wardrop
Journal:  Br J Anaesth       Date:  2000-02       Impact factor: 9.166

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Reliability of clinical monitoring to assess blood volume in critically ill patients.

Authors:  C R Shippy; P L Appel; W C Shoemaker
Journal:  Crit Care Med       Date:  1984-02       Impact factor: 7.598

7.  A novel approach to measuring circulating blood volume: the use of a hemoglobin-based oxygen carrier in a rabbit model.

Authors:  J S Jahr; F Lurie; S Xi; M Golkaryeh; O Kuznetsova; R Kullar; B Driessen
Journal:  Anesth Analg       Date:  2001-03       Impact factor: 5.108

8.  BLOOD VOLUME IN CLINICAL SHOCK. I. MIXING TIME AND DISAPPEARANCE RATE OF T-1824 IN NORMAL SUBJECTS AND IN PATIENTS IN SHOCK; DETERMINATION OF PLASMA VOLUME IN MAN FROM 10-MINUTE SAMPLE.

Authors:  R P Noble; M I Gregersen; P M Porter; A Buckman
Journal:  J Clin Invest       Date:  1946-03       Impact factor: 14.808

9.  Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.

Authors:  Avani C Modi; Shanna M Guilfoyle; Diego A Morita; Tracy A Glauser
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

Review 10.  Goals for the resuscitation of shock.

Authors:  R G Fiddian-Green; U Haglund; G Gutierrez; W C Shoemaker
Journal:  Crit Care Med       Date:  1993-02       Impact factor: 7.598

View more
  7 in total

1.  Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.

Authors:  Baobing Zhao; Yang Mei; Lan Cao; Jingxin Zhang; Ronen Sumagin; Jing Yang; Juehua Gao; Matthew J Schipma; Yanfeng Wang; Chelsea Thorsheim; Liang Zhao; Timothy Stalker; Brady Stein; Qiang Jeremy Wen; John D Crispino; Charles S Abrams; Peng Ji
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

2.  Characterization of the Rabbit as an In Vitro and In Vivo Model to Assess the Effects of Fibrinogenolytic Activity of Snake Venom on Coagulation.

Authors:  Vance G Nielsen; Elda E Sánchez; Daniel T Redford
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-08-06       Impact factor: 4.080

3.  An innovative approach for serial injection in marginal vein and blood collection from auricular artery in New Zealand white Rabbit.

Authors:  Prathap Moothamadathil Baby; Sanu Susan Jacob; Rajesh Kumar; Pramod Kumar
Journal:  MethodsX       Date:  2017-11-11

Review 4.  Evans Blue Dye: A Revisit of Its Applications in Biomedicine.

Authors:  Linpeng Yao; Xing Xue; Peipei Yu; Yicheng Ni; Feng Chen
Journal:  Contrast Media Mol Imaging       Date:  2018-04-22       Impact factor: 3.161

5.  Serial blood volume estimation in rabbits using trivalent chromium - An exploratory study.

Authors:  Prathap Moothamadathil Baby; Pramod Kumar; Rajesh Kumar; Sanu Susan Jacob; Dinesh Rawat; Binu Vs; Kalesh M Karun; Nishanth B Bhat
Journal:  MethodsX       Date:  2019-05-10

6.  A Modified Carbon Monoxide Breath Test for Measuring Erythrocyte Lifespan in Small Animals.

Authors:  Yong-Jian Ma; Hou-De Zhang; Yong-Qiang Ji; Guo-Liang Zhu; Jia-Liang Huang; Li-Tao Du; Ping Cao; De-Yue Zang; Ji-Hui Du; Rong Li; Lei Wang
Journal:  Biomed Res Int       Date:  2016-05-12       Impact factor: 3.411

7.  Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope.

Authors:  M Rizwan Sohail; Zerelda Esquer Garrigos; Claude S Elayi; Kun Xiang; John N Catanzaro
Journal:  Pacing Clin Electrophysiol       Date:  2020-03-05       Impact factor: 1.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.